Drug Shortage Report for RIZATRIPTAN ODT
Report ID | 28900 |
Drug Identification Number | 02446111 |
Brand name | RIZATRIPTAN ODT |
Common or Proper name | RIZATRIPTAN ODT |
Company Name | SIVEM PHARMACEUTICALS ULC |
Market Status | MARKETED |
Active Ingredient(s) | RIZATRIPTAN |
Strength(s) | 5MG |
Dosage form(s) | TABLET (ORALLY DISINTEGRATING) |
Route of administration | ORAL |
Packaging size | 6 |
ATC code | N02CC |
ATC description | ANTIMIGRAINE PREPARATIONS |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | 2017-12-04 |
Actual start date | 2017-12-06 |
Estimated end date | 2018-02-23 |
Actual end date | 2018-02-23 |
Shortage status | Resolved |
Updated date | 2018-02-26 |
Company comments | Temporarily unavailable |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 4705 DOBRIN STREET SAINT-LAURENT, QUEBEC CANADA H4R 2P7 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v10 | 2018-02-26 | French | Compare |
v9 | 2018-02-26 | English | Compare |
v8 | 2018-02-14 | French | Compare |
v7 | 2018-02-14 | English | Compare |
v6 | 2017-12-12 | French | Compare |
v5 | 2017-12-12 | English | Compare |
v4 | 2017-12-05 | English | Compare |
v3 | 2017-11-10 | French | Compare |
v2 | 2017-11-10 | English | Compare |
v1 | 2017-11-10 | English | Compare |
Showing 1 to 10 of 10